Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. NDAQ
9. CRM
10. CRWV

Go back to Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments

Avid Bioservices (CDMO) Tops Q3 EPS by 2c, Offers Guidance

March 13, 2023 4:27 PM EDT

Avid Bioservices (NASDAQ: CDMO) reported Q3 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $38 million versus the consensus estimate of $36.32 million.

GUIDANCE:

Avid Bioservices sees FY2023 revenue of $145-150 million, versus the... More